Search results
FDA Approves New Bladder Cancer Drug
Medscape· 5 days agoThe first-in-class agent is approved alongside bacillus Calmette-Guérin to treat certain non–muscle-invasive bladder cancers that do not respond to...
Renowned Peruvian investigative reporter battles criminalized smear campaign — and cancer
Seattle Times· 59 minutes agoIn an illustrious career, Gustavo Gorriti has endured death threats from drug traffickers, survived Peru’s harrowing Shining Path insurgency and a kidnapping by silencer-toting ...
Merck raises 2024 profit forecast on strong sales of cancer drug Keytruda
Reuters via Yahoo Finance· 3 days ago(Reuters) -Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of...
Europe Recommends Three Cancer Drugs
Medscape· 2 days agoThe European Medicines Agency has recommended Fruzaqla, Truqap, and Eribulin Baxter for use in the treatment of specific colorectal and breast cancers.
Rakovina Therapeutics: AI a “paradigm shift” for cancer drug development
Proactive Investors· 4 days agoTeaming up with Dr. Artem Cherkasov from the University of British Columbia, Rakovina gained...
FDA approves bladder cancer treatment by Culver City company
LA Times via Yahoo News· 5 days agoThe Food and Drug Administration has approved Culver City-based ImmunityBio's treatment for bladder ...
Mum thought she was just 'very tired' before being given devastating diagnosis
Daily Express· 3 hours agoWhen Cathy Hunt first started to feel “very tired” she thought it was just caused by an infection. A...
Patient, 59, 'at death's door' before cancer drug ‘eradicated’ disease in months
The US Sun· 5 days agoA MAN "at death's door" after running out of treatment options for leukaemia became the second...
Cancer drug trial provides lessons for future
Medical Xpress· 3 days agoA cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor removal ...
Exeliom to focus on gastric cancer landscape with immune modulating drug
Clinical Trials Arena via Yahoo Finance· 2 days agoParis-based Exeliom Biosciences will focus Phase III efforts of its immune modulating drug EXL01 in...
